Welcome to Epidemiology 2021
After Successfull completion of Epidemiology 2019, EuroSciCon is hosting its event to next level as “International Conference on Epidemiology and Infection 2021” which will be held during August 30-31, 2021 in Frankfurt, Germany. We are pleased to invite you all to attend this event as a Oral Speaker, Video and E-Poster Presentation, Delegate. The topic of the current year's gathering is New Challenges, Risk Managing Concepts for Epidemiology and Public Health which will give a worldwide Platform to all Epidemiologists, Doctors, Researchers, Students to talk on present and future of Epidemiology and Infection.
Hear, learn and explore the Latest Research involved in the field of Epidemiology and Public Health.
Benefits of Attending:
- Exchange ideas and network with leading healthcare experts, Epidemiologists, researchers, clinicians, students, public health professionals and researchers from more than 40 countries.
- Discuss ways to collaborate in putting quality initiatives in place throughout the Epidemiology and Infectious Diseases and Epidemiology and Public Health.
- Participants can gain direct access to a core audience of professionals and decision makers and can increase visibility through branding and networking at the conference.
- Learn and discuss key news and challenges with senior level speakers.
- With presentations, panel discussions, round-table discussions, and workshops, we cover every topic from top to bottom, from global macro issues to strategies to tactical issue
Academic researcher, Epidemiologists, Healthcare experts, Researchers, Medical colleges, Training institute, Epidemiology Societies & Association, Medical & Pharmacy, Companies, Software development companies, Business entrepreneurs, Public Health experts
Who should attend?
Scientists and researchers related to the broad areas of Epidemiology, Health care, Nutrition & Infectious Diseases are most likely to attend Epidemiology 2021 and utilize the scope of extending their skills, and their work on basic and significant applications. The Epidemiology 2021 will be useful to participants from both Industrial as well as Academic fields in all the domains of Health care sectors. All other target audience includes:
- Health care experts
- Nurse practitioners
- Health care analysts
- Business delegates
- Advertising and Promotion Agency Executives
- Young Researchers
Why to attend?
Epidemiology 2021 conference brings together experts, leading researchers, scholars, scientists, professors from fields of Health care, Epidemiology, Nutrition and other related areas to interact and exchange ideas about the state of the art technologies related to Infectious Diseases and Epidemiology. The conference will also provide an insightful understanding to the issues arising out of the Epidemiology and Infectious Diseases and the future concern and remedies from that. Epidemiology 2021 provides an opportunity to interact with eminent Scientists, researchers, Business Leaders, experts from all over the world.
American Board of Emergency Medicine | American Board of Family Medicine | American Board of Internal Medicine | American Board of Medical Genetics | American Board of Medical Specialties | American Board of Neurological Surgery | Nutrition Conferences | American Board of Obstetrics and Gynaecology | American Board of Ophthalmology | American Board of Orthopaedic Surgery |American Board of Otolaryngology | American Board of Pathology | American Board of Paediatrics | American Board of Preventive Medicine |American Board of Psychiatry and Neurology | Cardiology Conferences | American Board of Radiology | American Board of Surgery | American Cancer Society | American College of Cardiology | American College of Chest Physicians
Sessions and Tracks
Public health is concerned with protecting the health of entire populations. These populations can be as small as a local neighbourhood, or as big as an entire country or region of the world. Public Health is a part of sciences, skills and convictions that is focused on the preservation. In descriptive epidemiology, scientists do use of available data to identify health related problems. Epidemiology and Demography
- Epidemiology and Community Health
- Epidemiology and Disability
- Epidemiology and Mental Health
- Epidemiology and Aging
- Epidemiology Evidence based practices.
Coronavirus Disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. The best way to prevent and slow down transmission is be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol based rub frequently and not touching your face.
1) Hydroxychloroquine and chloroquine
Chloroquine and hydroxychloroquine are drugs derived from the quinoline molecule. Both are used as antimalarial blood schizonticides, and hydroxychloroquine is also frequently used as an antirheumatic. Their mechanism of action is not entirely understood. However, despite their varying therapeutic dosage and toxicity, both drugs have similar clinical indications and side effects. One of their most serious side effects is retinal toxicity, referred to as 4AQ retinopathy or chloroquine retinopathy, which must be screened for in all cases of long-term use.
2) Blood Plasma Therapy
Blood plasma is a 'yellowish liquid' component of blood that holds the blood cells in whole blood in suspension. It is the liquid part of the blood that carries cells and proteins throughout the body. It makes up about 55% of the body's total blood volume. Plasma therapy uses blood donated by recovered patients to introduce antibodies in those under treatment. We take a look at what convalescent plasma therapy is, the benefits and risks involved in the potential treatment, what past research says about it, and more.
The convalescent plasma therapy aims at using antibodies from the blood of a recovered Covid-19 patient to treat those critically affected by the virus. This therapy's concept is simple and is based on the premise that the blood of a patient who has recovered from Covid-19 contains antibodies with the specific ability of fighting novel corona virus. The theory is that the recovered patient's antibodies, once ingested into somebody under treatment, will begin targeting and fighting the novel corona virus in the second patient.
Favipiravir (T-705; 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Favipiravir is effective against a wide range of types and subtypes of influenza viruses, including strains resistant to existing anti-influenza drugs. Of note is that favipiravir shows anti-viral activities against other RNA viruses such as arena viruses, bunya viruses and filoviruses, all of which are known to cause fatal hemorrhagic fever. These unique anti-viral profiles will make favipiravir a potentially promising drug for specifically untreatable RNA viral infections.
No specific antiviral drug has been proven effective for treatment of patients with severe corona virus disease 2019 (COVID-19). Remdesivir (GS-5734), a nucleoside analogue pro-drug, has inhibitory effects on pathogenic animal and human corona viruses, including severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) in vitro, and inhibits Middle East respiratory syndrome corona virus, SARS-CoV-1, and SARS-CoV-2 replication in animal models.
Emerging infectious diseases are induced by various microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread from one person to another. Infectious Disease Epidemiology helps us to understand the correlations of contaminating agents, their hosts, vectors and environment. This information helps in understanding of how disease patterns vary among populations and how that impacts development of advanced therapies and treatment interventions.
- Epidemiology and Diseases
- Epidemiology and Zoonosis
- Epidemiology and Etiologic
Contamination Counterproductive action and control is required to keep the transmission of Infectious ailments in all social frameworks. These maladies are typically caused by Microscopic organisms and can be spread by human to human contact, creature to human contact, human contact with a contaminated surface, Airborne disease through little beads of uncontrollable operators suspended perceptible all around lastly, by such regular vehicles as water. Infection control and Counteractive action requests a basic comprehension of the study of disease transmission of maladies, by a little chance factors that expand quiet defencelessness to contamination, and the methodology where medicines that may bring about diseases.
The Epidemiology of Cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments. The most significant risk factor is age. Cancer Epidemiology closely mirrors risk factor spread in various countries. Hepatocellular Carcinoma (liver cancer) is rare in the West but is the main cancer in China and neighbouring countries, most likely due to the endemic presence of Hepatitis B and aflatoxin in that population.